APA

Fainardi E., Rizzo R., Melchiorri L., Castellazzi M., Govoni V., Caniatti L., Paolino E., Tola M. R., Granieri E. & Baricordi O. R. (20040405). Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy. : Journal of neuroimmunology.

Chicago

Fainardi Enrico, Rizzo Roberta, Melchiorri Loredana, Castellazzi Massimiliano, Govoni Vittorio, Caniatti Luisa, Paolino Ezio, Tola Maria Rosaria, Granieri Enrico and Baricordi Olavio Roberto. 20040405. Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy. : Journal of neuroimmunology.

Harvard

Fainardi E., Rizzo R., Melchiorri L., Castellazzi M., Govoni V., Caniatti L., Paolino E., Tola M. R., Granieri E. and Baricordi O. R. (20040405). Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy. : Journal of neuroimmunology.

MLA

Fainardi Enrico, Rizzo Roberta, Melchiorri Loredana, Castellazzi Massimiliano, Govoni Vittorio, Caniatti Luisa, Paolino Ezio, Tola Maria Rosaria, Granieri Enrico and Baricordi Olavio Roberto. Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy. : Journal of neuroimmunology. 20040405.